Term
Generic and 3 letter code
for Norvir |
|
Definition
|
|
Term
|
Definition
600mg bid (titrate to avoid GI)
or
100-400mg/day as booster in combination with other PI |
|
|
Term
Norvir
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|
Term
Generic and 3 letter code for
Crixivan |
|
Definition
|
|
Term
|
Definition
800mg q8h
or
800mg bid + RTV 100-200mg bid |
|
|
Term
Crixivan
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|
Term
Generic and 3 letter code for
Kaletra |
|
Definition
lopinavir/ritonavir
LPV/r |
|
|
Term
|
Definition
400/100mg bid
or
800/200mg qd (naive only) |
|
|
Term
Kaletra
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|
Term
Generic and 3 letter code for
Lexiva |
|
Definition
|
|
Term
|
Definition
1400mg bid (tx naive)
or
1400mg + RTV 200mg qd (tx naive)
or
700mg + RTV 100mg bid
(tx naive or experienced)
|
|
|
Term
Lexiva
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
substrate, inhibitor, and inducer |
|
|
Term
Generic and 3 letter code for
Reyataz |
|
Definition
|
|
Term
|
Definition
400mg qd (tx naive)
or
300mg + RTV 100mg qd
(tx experienced or pts taking
efavirenz or tenofovir) |
|
|
Term
Reyataz
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|
Term
Generic and 3 letter code for
Viracept |
|
Definition
|
|
Term
|
Definition
750mg tid
or
1250mg bid
(never give with RTV) |
|
|
Term
Viracept
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|
Term
Generic and 3 letter code for
Aptivus |
|
Definition
|
|
Term
|
Definition
500mg bid + RTV 200mg bid |
|
|
Term
Aptivus
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
substrate and inducer
if given with RTV it becomes a
CYP3A4 inhibitor |
|
|
Term
Generic and 3 letter code for
Invirase |
|
Definition
|
|
Term
|
Definition
|
|
Term
Invirase
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|
Term
Generic and 3 letter code for
Prezista |
|
Definition
|
|
Term
|
Definition
|
|
Term
Prezista
CYP3A4 substrate, inhibitor, or inducer |
|
Definition
|
|